Chronic lymphocytic leukemia (CLL) is the most common leukemia in Western countries and is characterized by the accumulation of malignant CD5+ CD19+ B cells with a defect in apoptosis and a very low proliferation rate [1]. The gene discussed is CD19; the disease is B-cell chronic lymphocytic leukemia.